[Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1997 and March 1998].
The annual multicenter studies on isolated bacteria from infections in general surgery and their antimicrobial susceptibility have been conducted in 19 facilities in Japan since July 1982. This paper describes the results obtained during the period from April 1997 to March 1998. The number of cases investigated as objectives was 215 for one year. A total of 420 strains (170 strains from primary infections and 250 strains from postoperative infections) were isolated from 174 cases (80.9% of total cases). In primary infections, the isolation rate of anaerobic bacteria was higher than in postoperative infections, while in postoperative infections, those of aerobic Gram-positive bacteria and Pseudomonas aeruginosa were higher than in primary infections. Among aerobic Gram-positive bacteria, the isolation rate of Enterococcus faecalis was the highest, followed by Staphylococcus aureus, which was frequently isolated from postoperative infections. Among anaerobic Gram-positive bacteria, Peptostreptococcus spp. and Streptococcus spp. were commonly isolated from both types of infections. Among aerobic Gram-negative bacteria, Escherichia coli was most predominantly isolated from primary infections, followed by P. aeruginosa, Klebsiella pneumoniae in this order, and from postoperative infections, P. aeruginosa was most predominantly isolated, followed by E. coli and K. pneumoniae. Among anaerobic Gram-negative bacteria, Bacteroides fragilis group was the majority of isolates from both types of infections. We found neither vancomycin nor arbekacin resistant strains of S. aureus, and found no vancomycin resistant strains of Enterococcus spp. The susceptibility of P. aeruginosa against carbapenems did not decline in the year 1997, while resistance of B. fragilis group against cephems advanced increasingly.
Mashita
K
K
Department of Surgery, Surugadai Hospital, Nihon University.
Shinagawa
N
N
Sato
T
T
Hirata
K
K
Katsuramaki
T
T
Mukaiya
M
M
Yura
J
J
Ishibiki
K
K
Ushijima
Y
Y
Manabe
T
T
Takeyama
H
H
Hasegawa
M
M
Aikawa
N
N
Yamazaki
M
M
Ishikawa
S
S
Iwai
S
S
Kato
K
K
Mizuno
A
A
Kinoshita
H
H
Morimoto
K
K
Konaga
E
E
Takeuchi
H
H
Fujimoto
M
M
Matsuura
Y
Y
Takesue
Y
Y
Tanimura
H
H
Ohnishi
H
H
Maeda
T
T
Yokoyama
T
T
Hiyama
E
E
Tanaka
N
N
Inoue
F
F
Iwagaki
H
H
Ikeda
S
S
Yasunami
Y
Y
Fuchimoto
S
S
Matsumoto
Y
Y
Suzuki
Y
Y
Tanaka
S
S
Kimura
H
H
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification*; D001420:Bacteria, Aerobic / Q000187:drug effects / Q000302:isolation & purification; D001421:Bacteria, Anaerobic / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects / Q000302:isolation & purification; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000302:isolation & purification; D011183:Postoperative Complications / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D013530:Surgical Wound Infection / Q000382:microbiology
D000900:Anti-Bacterial Agents